The UK was the highest ranked country for those offshoring pharma R&D, raising questions about its pharma industry’s attractiveness.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best immunotherapy stocks to buy according to hedge funds. RBC Capital reiterated a Hold rating on Regeneron Pharmaceuticals, Inc.

And there's more than one way to monetize this technology.

UPDATE: This post was updated at 11:49 a.m. with some remarks from Wednesday’s plant announcement. Another of the world’s top ...

Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive ...

The U.S. is the biggest single market for most pharma and biotech firms. Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five get a majority of their total sales from ...

Shares of Evoke Pharma Inc (NASDAQ:EVOK) are trading sharply higher Wednesday morning after the specialty pharmaceutical company announced it has received a Notice of Allowance from the U.S. Patent ...

The new year is shaping up to be a defining year following a dramatic 2025, and one where the impact from last year's developments will crystallize.

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...

As more states enact laws that regulate how AI is used in healthcare marketing, pharma marketers will need to build guardrails around transparency, bias and human-in-the-loop.